In blow to com­pounders, FDA reaf­firms tirzepatide short­age is over

The FDA has reaf­firmed that the short­age of Eli Lil­ly’s block­buster obe­si­ty and di­a­betes med­ica­tions is re­solved, deal­ing a blow to phar­ma­cies and tele­health ser­vices …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER